Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
OctaAlpha1
/
Octapharma
Welcome,
Profile
Billing
Logout
0 Diseases
1 Trial
1 Trial
1 News
||||||||||
OctaAlpha1
/
Octapharma
Enrollment change, Trial withdrawal:
Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency
(clinicaltrials.gov) - Apr 10, 2018
P2
, N=0, Withdrawn,
Sponsor: Octapharma
N=40 --> 0 | Not yet recruiting --> Withdrawn
|
|||||||||
OctaAlpha1
/
Octapharma
New P2 trial:
Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency
(clinicaltrials.gov) - Dec 28, 2017
P2
, N=40, Not yet recruiting,
Sponsor: Octapharma